Q1 and Q2 selection, Q3, IVRT, IVPT, pharmacokinetic and pharmacodynamic evaluation of topical generic product
The Cutivate<sup>®</sup> cream 0.05%, and proposed generic product Fluticasone Propionate cream 0.05% formulations are bioequivalent and have a favorable safety profile.
Authors
- Yulan Chen
- Yijie Zhu
- Yongbo Liu (ORCID: https://orcid.org/0000-0003-3569-0753)
- Jie Feng (ORCID: https://orcid.org/0009-0008-6338-5178)
- Om Shelke
Institutions
- Central South University (CN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-04-04
- DOI
- https://doi.org/10.1080/03639045.2025.2486487
- Citations
- 3
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 10.48